Affinity-Asset-Advisors

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-14
Total Holdings
91
Total Value
976714470
Accession Number
0001999371-25-006074
Form Type
13F-HR
Manager Name
Affinity-Asset-Advisors
Data Enrichment
86% identified
78 identified13 unidentified

Holdings

91 positions
Manager:
Search and click to pin securities to the top
008064107
Shares:800.0K
Value:$2.0M
Cullinan Therapeutics, Inc.
Shares:263.8K
Value:$2.0M
28658R106
Shares:1.5M
Value:$1.8M
OnKure Therapeutics, Inc.
Shares:394.2K
Value:$1.7M
NewAmsterdam Pharma Co N.V.
Shares:75.0K
Value:$1.5M
Tourmaline Bio, Inc.
Shares:100.0K
Value:$1.5M
Roivant Sciences Ltd.
Shares:150.0K
Value:$1.5M
Nkarta, Inc.
Shares:800.0K
Value:$1.5M
Anteris Technologies Global Corp.
Shares:390.0K
Value:$1.4M
MBX Biosciences, Inc.
Shares:175.0K
Value:$1.3M
Third Harmonic Bio, Inc.
Shares:370.0K
Value:$1.3M
89bio, Inc.
Shares:175.0K
Value:$1.3M
Abivax S.A.
Shares:200.0K
Value:$1.3M
Olema Pharmaceuticals, Inc.
Shares:325.0K
Value:$1.2M
NextCure, Inc.
Shares:2.3M
Value:$1.1M
MeiraGTx Holdings plc
Shares:150.0K
Value:$1.0M
Vaxcyte, Inc.
Shares:25.0K
Value:$944.0K
Viking Therapeutics, Inc.
Shares:25.0K
Value:$603.8K
SUTRO BIOPHARMA, INC.
Shares:752.7K
Value:$489.7K
Context Therapeutics Inc.
Shares:660.6K
Value:$404.3K